We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTBK
1926
DELISTED
Heritage Commerce
HTBK
| $1.4K | ﹤0.01% |
161
-3,054
| -95% | -$24.8K |
|
1927
Adicet Bio
ACET
$79.7M
| $1.4K | ﹤0.01% |
+72
| New | +$1.93K |
|
1928
WidePoint Corp
WYY
$112M
| $1.39K | ﹤0.01% |
332
| – | – |
|
|
CTV
1929
DELISTED
Innovid Corp.
CTV
| $1.39K | ﹤0.01% |
+751
| New | +$1.61K |
|
1930
FS Bancorp
FSBW
$350M
| $1.39K | ﹤0.01% |
38
-14
| -27% | -$459 |
|
|
STRR
1931
Star Equity Holdings
STRR
$36.9M
| $1.38K | ﹤0.01% |
83
-14
| -14% | -$229 |
|
1932
Anika Therapeutics
ANIK
$280M
| $1.37K | ﹤0.01% |
+54
| New | +$1.4K |
|
1933
Sera Prognostics
SERA
$78.5M
| $1.37K | ﹤0.01% |
231
+50
| +28% | +$447 |
|
1934
Travelzoo
TZOO
$57.3M
| $1.34K | ﹤0.01% |
176
-353
| -67% | -$3K |
|
|
JBIO
1935
Jade Biosciences
JBIO
$1.11B
| $1.29K | ﹤0.01% |
22
+20
| +1,000% | +$13.3K |
|
1936
Tenaya Therapeutics
TNYA
$150M
| $1.28K | ﹤0.01% |
414
+413
| +41,300% | +$1.71K |
|
|
TCS
1937
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $1.28K | ﹤0.01% |
158
+47
| +42% | +$571 |
|
1938
Invivyd
IVVD
$245M
| $1.22K | ﹤0.01% |
+1,108
| New | +$2.45K |
|
1939
Quanex
NX
$968M
| $1.13K | ﹤0.01% |
+41
| New | +$1.36K |
|
1940
Comscore
SCOR
$78.7M
| $1.11K | ﹤0.01% |
78
+7
| +10% | +$100 |
|
1941
The Honest Company
HNST
$583M
| $1.09K | ﹤0.01% |
372
-178
| -32% | -$529 |
|
|
MAPS
1942
DELISTED
WM TECHNOLOGY INC A
MAPS
| $1.07K | ﹤0.01% |
1,025
| – | – |
|
1943
National Bank Holdings
NBHC
$1.86B
| $1.05K | ﹤0.01% |
27
-36
| -57% | -$1.28K |
|
1944
Veritone
VERI
$112M
| $1.01K | ﹤0.01% |
448
| – | – |
|
1945
H.B. Fuller
FUL
$2.74B
| $1K | ﹤0.01% |
13
-1
| -7% | -$78 |
|
1946
SandRidge Energy
SD
$555M
| $983 | ﹤0.01% |
+76
| New | +$1.05K |
|
1947
Hyliion Holdings
HYLN
$705M
| $980 | ﹤0.01% |
605
| – | – |
|
1948
Origin Bancorp
OBK
$1.68B
| $952 | ﹤0.01% |
+30
| New | +$918 |
|
1949
Biote Corp
BTMD
$39.9M
| $904 | ﹤0.01% |
+121
| New | +$746 |
|
1950
BJ's Restaurants
BJRI
$1.28B
| $902 | ﹤0.01% |
+26
| New | +$892 |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.